Related Experiment Video
Updated: Jun 13, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Dissecting genetic predisposition to inflammatory bowel disease: current progress and prospective application
Vito Annese1, Anna Latiano, Orazio Palmieri
1Unità e Laboratorio di Gastroenterologia ed Endoscopia, Ospedale I.R.C.C.S 'Casa Sollievo della Sofferenza', Viale Cappuccini, 1-71013 San Giovanni Rotondo (Fg), Italy. v.annese@operapadrepio.it
Genetic susceptibility to inflammatory bowel disease (IBD) has advanced, identifying genes like CARD15. Further research will explore gene-environment interactions in IBD pathogenesis.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- Significant advancements in understanding genetic susceptibility to inflammatory bowel disease (IBD) have been made over the last decade.
- Multiple genes and loci associated with IBD risk have been identified through linkage, fine-mapping, and candidate-gene studies.
Purpose of the Study:
- To review the current state of genetic research in IBD.
- To highlight key identified genes and those requiring further validation.
- To discuss the implications of genetic findings for understanding IBD pathogenesis and heterogeneity.
Main Methods:
- Review of linkage, fine-mapping, and candidate-gene studies in IBD genetics.
- Analysis of identified susceptibility genes, including CARD15, MHC, and IBD5.
- Discussion of emerging genomic and proteomic methodologies.
Main Results:
- Several IBD susceptibility genes and loci have been identified, with CARD15 being the most replicated.
- Numerous other candidate genes require further confirmation.
- The role of CARD15 variants in innate immune response to gut bacteria is implicated.
Conclusions:
- Genetic research has significantly advanced the understanding of IBD susceptibility.
- Further investigation is needed to elucidate the precise mechanisms linking genetic variants to IBD pathogenesis.
- Future genomic and proteomic studies will enhance understanding of IBD heterogeneity and gene-environment interactions.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
